Yahoo Web Search

  1. Ads
    related to MERCK & CO., INC
  1. Merck & Co., Inc. (NYSE:MRK) Has Attractive Fundamentals

    Simply Wall St. via Yahoo FinanceMay 31 17:13 PM

    Help shape the future of investing tools and you could win a $250 gift card! As an investor, I look for investments which does not compromise one fundamental factor for another. By this I mean ...

  2. Is Merck & Co., Inc. (MRK) A Good Stock To Buy ?

    Insider Monkey via Yahoo FinanceJun 06 20:40 PM

    "Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn't by much. Nevertheless, we were still able to identify in advance a ...

  3. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MRK.

  4. Merck's Antibiotic Zerbaxa Gets FDA Nod for New Indication

    Zacks via Yahoo FinanceJun 04 14:18 PM

    Merck & Co., Inc. MRK gained FDA approval for a supplemental new drug application looking for label expansion of its antibacterial medicine, Zerbaxa for two types of pneumonia ...

  5. Merck & Co., Inc. MRK shares have performed well this year so far. Merck’s shares have risen 6.2% this year so far compared with the industry’s increase of 0.7%.

  6. Merck's Keytruda Improves 5-Year Survival in Lung Cancer

    Zacks via Yahoo FinanceJun 03 13:39 PM

    Merck & Co., Inc. MRK presented encouraging five-year survival data on its PD-L1 inhibitor, Keytruda in patients with advanced non-small cell lung cancer (NSCLC) at the ...

  7. Merck (MRK) to Buy Private Biotech Tilos for Up to $773M

    Zacks via Yahoo FinanceJun 11 12:53 PM

    Merck & Co., Inc. MRK announced a definitive deal to buy private biotech Tilos Therapeutics for a total potential purchase price of up to $773 million. The deal includes ...

  8. Merck & Co., Inc. MRK announced that the FDA has granted approval to its blockbuster PD-L1 inhibitor, Keytruda for first-line treatment of recurrent or metastatic head and ...

  9. Merck Strikes $773M Deal For Privately Held Tilos Therapeutics

    Benzinga via Yahoo FinanceJun 10 17:19 PM

    Keeping in line with the biotech M&A frenzy seen for much of the year, Merck & Co., Inc. NYSE: MRK) announced a deal Monday to buy Tilos Therapeutics. Only recently, the ...

  10. Merck wins U.S. FDA approval for expanded use of antibiotic

    Reuters via Yahoo FinanceJun 03 19:41 PM

    The approval is based on the treatment's late-stage trial results, which showed that Merck's drug, Zerbaxa, was as effective as another antibacterial drug. Hospital-acquired pneumonia ...

  1. Ads
    related to MERCK & CO., INC